Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038362 (
stomatitis
)
8,852
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Objective To prepare a lentiviral vector expressing
LLGL2
and establish KYSE450 and TE-1 cell lines for the stable expression of
LLGL2
. Methods The full-length
LLGL2
sequence was amplified by high-fidelity PCR, and then it was inserted into pCDH-CMV-IRES-GFP-EF1-Puro vectors. The recombinant plasmid was confirmed by double enzyme digestion and sequencing. After co-infection of pCDH-CMV-
LLGL2
-IRES- GFP-EF1-Puro with vesicular
stomatitis
virus glycoprotein (VSVG) and PHR into HEK293T cells, the lentivirus was harvested and used for infecting esophageal squamous cell carcinoma cell lines including KYSE450 and TE-1 cells. These two cell lines infected with the lentivirus were screened with puromycin, and the stable cell lines were further confirmed with green fluoresence and Western blotting. Results Dual-enzyme digestion and sequencing confirmed that the pCDH-CMV-
LLGL2
-IRES-GFP-EF1-Puro vector, a lentiviral expression vector for the overexpression of
LLGL2
, was successfully constructed through high-fidelity PCR and ligation. Western blotting showed the increased expression level of
LLGL2 protein
in KYSE450 and TE-1 stable cell lines compared with the controls. Conclusion The experiment successfully established KYSE450 and TE-1 stable cell lines for the overexpression of
LLGL2
.
...
PMID:[Establishment of esophageal squamous carcinoma cell lines stably over-expressing LLGL2]. 2827 13